HCV replicon inhibitors (Arrow Therapeutics)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameHCV replicon inhibitors (Arrow Therapeutics)
Drug Alias Nameaminopyrazolopyrimidines (Arrow)hepatitis C virus replicon inhibitors (Arrow Therapeutics)A-890A-63890
ClassificationSmall molecules
Mechanisms of ActionVirus replication inhibitors
TargetsUpdating
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesArrow Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArrow Therapeutics Ltd
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A